Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Wearable Injector Devices Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Wearable Injector Devices Market Status and Forecast (2016-2027)
      • 1.3.2 Global Wearable Injector Devices Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Wearable Injector Devices Supply by Company

    • 2.1 Global Wearable Injector Devices Sales Volume by Company
    • 2.2 Global Wearable Injector Devices Sales Value by Company
    • 2.3 Global Wearable Injector Devices Price by Company
    • 2.4 Wearable Injector Devices Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Wearable Injector Devices Market Status by Category

    • 3.1 Wearable Injector Devices Category Introduction
      • 3.1.1 Disposable
      • 3.1.2 Reusable
    • 3.2 Global Wearable Injector Devices Market by Category
      • 3.2.1 Global Wearable Injector Devices Sales Volume by Category (2016-2021)
      • 3.2.2 Global Wearable Injector Devices Sales Value by Category (2016-2021)
      • 3.2.3 Global Wearable Injector Devices Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Wearable Injector Devices Market Status by End User/Segment

    • 4.1 Wearable Injector Devices Segment by End User/Segment
      • 4.1.1 Oncology
      • 4.1.2 Diabetes
      • 4.1.3 Cardiovascular Diseases
      • 4.1.4 Autoimmune Disorder
      • 4.1.5 Infectious Diseases
      • 4.1.6 Others
    • 4.2 Global Wearable Injector Devices Market by End User/Segment
      • 4.2.1 Global Wearable Injector Devices Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Wearable Injector Devices Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Wearable Injector Devices Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Wearable Injector Devices Market Status by Region

    • 5.1 Global Wearable Injector Devices Market by Region
      • 5.1.1 Global Wearable Injector Devices Sales Volume by Region
      • 5.1.2 Global Wearable Injector Devices Sales Value by Region
    • 5.2 North America Wearable Injector Devices Market Status
    • 5.3 Europe Wearable Injector Devices Market Status
    • 5.4 Asia Pacific Wearable Injector Devices Market Status
    • 5.5 Central & South America Wearable Injector Devices Market Status
    • 5.6 Middle East & Africa Wearable Injector Devices Market Status

    6 North America Wearable Injector Devices Market Status

    • 6.1 North America Wearable Injector Devices Market by Country
      • 6.1.1 North America Wearable Injector Devices Sales Volume by Country (2016-2021)
      • 6.1.2 North America Wearable Injector Devices Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Wearable Injector Devices Market Status

    • 7.1 Europe Wearable Injector Devices Market by Country
      • 7.1.1 Europe Wearable Injector Devices Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Wearable Injector Devices Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Wearable Injector Devices Market Status

    • 8.1 Asia Pacific Wearable Injector Devices Market by Country
      • 8.1.1 Asia Pacific Wearable Injector Devices Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Wearable Injector Devices Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Wearable Injector Devices Market Status

    • 9.1 Central & South America Wearable Injector Devices Market by Country
      • 9.1.1 Central & South America Wearable Injector Devices Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Wearable Injector Devices Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Wearable Injector Devices Market Status

    • 10.1 Middle East & Africa Wearable Injector Devices Market by Country
      • 10.1.1 Middle East & Africa Wearable Injector Devices Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Wearable Injector Devices Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Wearable Injector Devices Manufacturing Cost Analysis
    • 11.5 Wearable Injector Devices Sales Channel and Distributors Analysis
      • 11.5.1 Wearable Injector Devices Sales Channel
      • 11.5.2 Wearable Injector Devices Distributors
    • 11.6 Wearable Injector Devices Downstream Major Buyers

    12 Global Wearable Injector Devices Market Forecast by Category and by End User/Segment

    • 12.1 Global Wearable Injector Devices Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Wearable Injector Devices Forecast by Category
      • 12.2.1 Global Wearable Injector Devices Sales Volume Forecast by Category
      • 12.2.2 Global Wearable Injector Devices Sales Value Forecast by Category
      • 12.2.3 Global Wearable Injector Devices Price Forecast by Category
    • 12.3 Global Wearable Injector Devices Forecast by End User/Segment
      • 12.3.1 Global Wearable Injector Devices Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Wearable Injector Devices Sales Value Forecast by End User/Segment
      • 12.3.3 Global Wearable Injector Devices Price Forecast by End User/Segment

    13 Global Wearable Injector Devices Market Forecast by Region/Country

    • 13.1 Global Wearable Injector Devices Market Forecast by Region (2022-2027)
      • 13.1.1 Global Wearable Injector Devices Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Wearable Injector Devices Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Ypsomed
      • 14.1.1 Company Information
      • 14.1.2 Wearable Injector Devices Product Introduction
      • 14.1.3 Ypsomed Wearable Injector Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 West Pharmaceutical Services, Inc.
      • 14.2.1 Company Information
      • 14.2.2 Wearable Injector Devices Product Introduction
      • 14.2.3 West Pharmaceutical Services, Inc. Wearable Injector Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 UNILIFE CORPORATION
      • 14.3.1 Company Information
      • 14.3.2 Wearable Injector Devices Product Introduction
      • 14.3.3 UNILIFE CORPORATION Wearable Injector Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 SteadyMed Therapeutics, Inc.
      • 14.4.1 Company Information
      • 14.4.2 Wearable Injector Devices Product Introduction
      • 14.4.3 SteadyMed Therapeutics, Inc. Wearable Injector Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Sensile Medical AGInsulet Corporation
      • 14.5.1 Company Information
      • 14.5.2 Wearable Injector Devices Product Introduction
      • 14.5.3 Sensile Medical AGInsulet Corporation Wearable Injector Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Johnson & Johnson Services, Inc.
      • 14.6.1 Company Information
      • 14.6.2 Wearable Injector Devices Product Introduction
      • 14.6.3 Johnson & Johnson Services, Inc. Wearable Injector Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 F. Hoffmann-La Roche Ltd
      • 14.7.1 Company Information
      • 14.7.2 Wearable Injector Devices Product Introduction
      • 14.7.3 F. Hoffmann-La Roche Ltd Wearable Injector Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Enable Injections
      • 14.8.1 Company Information
      • 14.8.2 Wearable Injector Devices Product Introduction
      • 14.8.3 Enable Injections Wearable Injector Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 CeQur SA.
      • 14.9.1 Company Information
      • 14.9.2 Wearable Injector Devices Product Introduction
      • 14.9.3 CeQur SA. Wearable Injector Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Buhler Motor GmbH
      • 14.10.1 Company Information
      • 14.10.2 Wearable Injector Devices Product Introduction
      • 14.10.3 Buhler Motor GmbH Wearable Injector Devices Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Becton
    • 14.12 Amgen

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Wearable Injector Devices market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Wearable Injector Devices market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Disposable
      Reusable

      Segmented by End User/Segment
      Oncology
      Diabetes
      Cardiovascular Diseases
      Autoimmune Disorder
      Infectious Diseases
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Ypsomed
      West Pharmaceutical Services, Inc.
      UNILIFE CORPORATION
      SteadyMed Therapeutics, Inc.
      Sensile Medical AGInsulet Corporation
      Johnson & Johnson Services, Inc.
      F. Hoffmann-La Roche Ltd
      Enable Injections
      CeQur SA.
      Buhler Motor GmbH
      Becton
      Amgen

      Buy now